In partnership with

🌞Good Monday Morning, Folks!

For months, the market treated Palantir the same way it treats every expensive stock it doesn’t fully understand: impressive story, impossible valuation, wait for the crash.

Then this week, two of Wall Street’s biggest names tore that script up.

Goldman Sachs and Barclays both upgraded PLTR within days of each other, citing a brand new growth lane called “sovereign AI.” The stock ripped as much as 10.8% on the week and closed Tuesday at a fresh all-time high.

Everyone’s talking about the upgrades.

Almost nobody’s talking about what happened in the options market at the exact same time.

That’s the part of this story I want to walk through today.

Missed Friday’s Playbook on Marvell’s $90 billion bet?

⚡ Quick Hits

The real issue is not whether retailers use AI to manage prices, but whether they start using personal data to decide what you should pay. Walmart has publicly said it will not use shopping history, income, or customer identity for individualized pricing even as it rolls out digital shelf labels nationwide. In plain English, AI can help with markdowns and inventory, but the line between efficient pricing and “surveillance pricing” is becoming a serious trust and regulatory issue.

Moderna has surged more than 500% this year and now trades 61% above Wall Street’s average price target, which naturally raises concerns that the rally has gone too far. The Fool’s view is more balanced: the stock could pause or pull back after such a huge run, but Moderna’s broader vaccine portfolio and cancer pipeline still give it meaningful long-term upside. The takeaway is that trimming gains may make sense, but the growth story is not finished.

Marvell is projecting that its business connecting AI chips and data centers could generate roughly $37.5 billion annually by fiscal 2031, helping support an ambitious $70 billion to $90 billion total revenue target. That optimism also lifted Ciena and Astera Labs, which benefit from the same networking and connectivity boom. The caution is valuation and customer concentration, with both names already trading at very rich multiples.

TOGETHER WITH OUR PARTNER

Most prompting advice stops at "be specific."

What’s the key to maintaining brand integrity at scale? A lot goes into it, but the teams that get it right have one thing in common: they know how to talk to AI models.

As teams speed up and the required creative volume balloons, communication matters more than ever— both with LLMs, and with the people around you. Creative teams need to focus on ideas, concepts, craft, while technology augments their manual execution demands.

Join our discussion on this evolution with Ari Murray, Chief Digital Officer at Salt and Stone, and get 5 tips for expert LLM prompting with ready to run prompts.

💡One Big Idea: PLTR Hit A New High On An Upgrade. Here’s The Part Of The Chart That Doesn’t Fit.

Palantir just got a rare one-two punch from Wall Street, and the stock actually delivered on it.

Goldman Sachs upgraded the stock to Buy with a $230 target on October 8. Barclays followed days later with a $265 target, about 32% above where the rest of the Street sits.

The obvious read: two heavyweight banks just found a new multi-hundred-billion-dollar market, and the stock broke to a record on the news.

That read isn’t wrong. It’s just not the whole story.

Because the same week the stock printed a new all-time high, the options desks flagged something that doesn’t usually show up on a breakout like this one.

Here’s the real question. If the smart money is this convinced, why does conviction look thin underneath the price?

📈 The Sovereign AI Upgrade Is Real Money, Not Just A Buzzword

Goldman’s note wasn’t a vague “we like the story” upgrade.

It came with a specific thesis. Governments are racing to build AI infrastructure they fully own, instead of renting it from someone else’s cloud.

That is sovereign AI.

Palantir has spent two decades earning exactly the kind of government trust this requires.

Barclays backing the same thesis with a target 32% above the Street average is not a small vote of confidence. That is the kind of double-confirmation that usually moves a stock for a real reason.

⚠️ The Bar Palantir Set For Itself Just Got Higher

Here’s where it gets uncomfortable.

Palantir guided Q3 revenue to $2.160 to $2.164 billion and adjusted operating income to $1.292 to $1.296 billion.

Over the last five quarters, it has beaten the top of its own guidance by 5.7% to 8.7% every single time.

Here’s the part that doesn’t get said enough. Shares still fell after two of those five beats.

Beating guidance hasn’t been enough on its own, and now the stock has to clear that bar from a record high instead of a cheap starting point.

At the same time, at least one market analysis flagged overbought technical signals alongside shrinking options open interest, meaning fewer new positions are being built into this move even as price keeps climbing. Not a crowd piling in. A crowd that’s already in, pushing the same chips around the table.

📉 What The Stock Is Telling You

Palantir closed Thursday at $209.05, up 5.17% on the day alone, and that close didn’t just approach a record, it set one.

The old high was $207.18, set back in November 2025. This week’s rally didn’t stall below that level, it ran straight through it.

What’s notable is the shape of the move, not just the size of it.

The stock gapped higher fast on the Goldman and Barclays headlines, the kind of move that usually brings a wave of new buyers chasing it through options.

Instead, open interest barely budged. That’s the quiet part of this chart nobody is putting a headline on.

If PLTR holds above $207 to $209 on real follow-through buying into earnings, this upgrade cycle is the real deal. If it slips back below that old high while RSI stays hot, the more likely story is a crowded trade resting on two analyst notes instead of a structural re-rating.

🔍 What I’d Watch Next

🏛️ The Next Sovereign AI Contract Announcement

If Palantir lands a named government deal explicitly using the sovereign AI framing Goldman just used, that converts this from an analyst thesis into a revenue line. If weeks pass with no follow-through, the thesis stays theoretical. The wildcard is a competitor, think Microsoft or Oracle, announcing a sovereign AI deal first and stealing the narrative.

📊 Options Open Interest Over The Next Two Weeks

Watch whether open interest starts building now that the upgrades are public. If it does, new money is confirming the move. If it keeps shrinking while price holds near highs, that’s a classic setup for a sharp pullback once the news cycle moves on.

💰 How Other Analysts Respond

Goldman and Barclays moved first. If three or four more shops follow with upgrades over the next two weeks, this becomes a consensus re-rating. If the rest of the Street stays on the sidelines, these two notes look more like outliers chasing a move that already happened.

📅 Palantir’s Next Earnings Print

I covered PLTR back in August at a much lower price in The Stock That Outran Its Own Analysts. The setup has changed since then. The bar is higher now, and the next print needs to show commercial and government revenue actually accelerating into this story, not just growing at the same pace it already was.

🌍 Broader AI Infrastructure Sentiment

Wider market jitters over AI infrastructure spending haven’t spared the AI trade generally this month. If that macro mood sours further, even a legitimately upgraded stock like PLTR can get dragged down with names that have weaker stories, simply because they trade in the same basket.

💥 My Take

I think the sovereign AI thesis is real.

Governments do not want to rent their most sensitive infrastructure from someone else’s cloud, and Palantir has spent twenty years building exactly the trust relationships that matter here.

But a good thesis and a good entry price are two different questions.

Because right now, the stock is pricing in flawless execution on a story that is still mostly analyst notes, not signed contracts, and it is doing so from a record high instead of a discount.

The options market quietly disagreeing with the headlines, even while price celebrates, tells me more than the upgrades themselves do.

I would rather buy this story after Q3 earnings confirm it than chase it on conviction borrowed from two research desks at the all-time high.

TOGETHER WITH OUR PARTNER

Unify Your Teams and Tech Stack With HubSpot

Connect your customer data, teams, and tools without the hassle of complex integrations or lengthy setups. One easy platform gives marketing, sales, and service teams a unified customer view and the tools to turn it into growth.

Why HubSpot and what's new
• Generate leads and automate marketing with Marketing Hub
• Build your pipeline and close more deals with Sales Hub
• Scale customer support and drive retention with Service Hub
• Keep customer data clean, connected, and actionable with one, unified platform

Join 306,000+ in over 135 countries using HubSpot to grow their businesses.

See what a more connected approach to growth can do for you and your team. Get setup quickly and start checking off your hardest tasks.

🧠 Final Thought

Analyst upgrades change how a stock gets discussed long before they change what a company has actually proven.

That gap is where most retail investors get hurt, buying the headline instead of the follow-through.

The options market rarely lies the way a press release can.

When price and positioning disagree, positioning is usually the one telling the truth.

Patience isn’t the opposite of conviction.

It’s what makes conviction worth having.

If One Big Idea sharpened your week, send it to one friend who needed it too.

🧠 What did you think of today's newsletter?

Login or Subscribe to participate

Stay Sharp,

— AK

Disclaimer: The content on this blog is for educational and informational purposes only and is not intended as financial, investment, tax, or legal advice. Investing in the stock market involves risks, including the loss of principal. The views expressed here are solely those of the author and do not represent any company or organization. Readers should conduct their own research and due diligence before making any financial decisions. The author and publisher are not responsible for any losses or damages resulting from the use of this information.

Reply

Avatar

or to participate